Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalBone marrow transplantation
DOIs
StateAccepted/In press - 2020

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this